RecombinantListeriaVaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7

Cancer Research - United States
doi 10.1158/0008-5472.can-04-1958
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Human Papillomavirus Type 16 Nucleoprotein E7 Is a Tumor Rejection Antigen.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Immunostimulatory Oligodeoxynucleotides Containing the CpG Motif Are Effective as Immune Adjuvants in Tumor Antigen Immunization

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription

mSphere
MicrobiologyMolecular Biology
2020English

Human Papillomavirus Type 16 E7 Oncoprotein mediatesCCNA1promoter Methylation

Cancer Science
Cancer ResearchMedicineOncology
2015English

Abrogation of Growth Arrest Signals by Human Papillomavirus Type 16 E7 Is Mediated by Sequences Required for Transformation.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1996English

The E7 Protein of Human Papillomavirus Type 16 Sensitizes Primary Human Keratinocytes to Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Regulation of the Cdc25A Gene by the Human Papillomavirus Type 16 E7 Oncogene

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Human Papillomavirus Type 16 E7 Up-Regulates AKT Activity Through the Retinoblastoma Protein

Cancer Research
Cancer ResearchOncology
2006English

The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy